FindTrial
Sign In

Study of discriminating benign and malignant pulmonary nodules based on non-invasive metabonomics

Study of discriminating benign and malignant pulmonary nodules based on non-invasive metabonomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057206
Enrollment
Unknown
Registered
2022-03-03
Start date
2022-03-21
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Gold Standard:1. Pathology report
2. 2-year imaging follow-up data were used to identify benign pulmonary nodules when pathological reports could not be obtained.
Index test:Metabolic profiling of saliva.

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-80 years, regardless of gender; 2. CT screening results showed that the size of lung nodules was 5-30 mm; 3. No lung nodule/lung cancer related treatment (including surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, interventional therapy, etc.); 4. Complete clinical data and imaging data; 5. Voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous tumor history; 2. A history of pulmonary infection within one month before enrollment; 3. Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
Metabolic profiling;—

Countries

China

Contacts

Public ContactBai Chunxue

Zhongshan Hospital Fudan University

bai.chunxue@zs-hospital.sh.cn+86 18621170011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026